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Specificity Mutants of the Binding Protein of the Oligopeptide
Transport System of Lactococcus lactis
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The kinetic properties of wild-type and mutant oligopeptide binding proteins of Lactococcus lactis were
determined. To observe the properties of the mutant proteins in vivo, the oppA gene was deleted from the
chromosome of L. lactis to produce a strain that was totally defective in oligopeptide transport. Amplified
expression of the oppA gene resulted in an 8- to 12-fold increase in OppA protein relative to the wild-type level.
The amplified expression was paralleled by increased bradykinin binding activity, but had relatively little effect
on the overall transport of bradykinin via Opp. Several site-directed mutants were constructed on the basis of
a comparison of the primary sequences of OppA from Salmonella enterica serovar Typhimurium and L. lactis,
taking into account the known structure of the serovar Typhimurium protein. Putative peptide binding-site
residues were mutated. All the mutant OppA proteins exhibited a decreased binding affinity for the high-affinity
peptide bradykinin. Except for OppA(D471R), the mutant OppA proteins displayed highly defective bradykinin
uptake, whereas the transport of the low-affinity substrate KYGK was barely affected. Cells expressing
OppA(D471R) had a similar Km for transport, whereas the Vmax was increased more than twofold as compared
to the wild-type protein. The data are discussed in the light of a kinetic model and imply that the rate of
transport is determined to a large extent by the donation of the peptide from the OppA protein to the
translocator complex.
In bacteria, the binding protein-dependent permeases con-
stitute an important group of transport systems for the uptake
of nutrients such as sugars, amino acids, anions, and peptides
(1, 8). In gram-negative bacteria, the systems consist of a
periplasmic substrate binding protein, a membrane-bound
complex formed by two hydrophobic integral membrane pro-
teins (or a single protein with two domains), and two mem-
brane-associated proteins that carry the ATP-binding cassette
motif (8). The periplasmic substrate binding protein is usually
present in large excess (18), serving to capture the substrate
with high affinity and to deliver it to the membrane-bound
complex. The substrate binding proteins determine the speci-
ficity of the transport systems and therefore the range of mol-
ecules that may enter the cell (31).
The oligopeptide transport system (Opp) possesses one of
the most versatile binding proteins, since it is able to handle a
large variety of peptides present in the medium. Experiments
with amino acid auxotrophic strains of Escherichia coli have
shown that the Opp system is able to transport peptides from
two to five amino acid residues, composed of a large variety of
natural and/or modified residues (24). Equilibrium dialysis ex-
periments with OppA of E. coli indicate that the protein has a
higher affinity for tri- and tetrapeptides than for di- and pen-
tapeptides (7). The Opp system of Lactococcus lactis is homol-
ogous to the Opp systems of enteric bacteria. As for many
other binding proteins in gram-positive bacteria, the OppA
protein is anchored to the cytoplasmic membrane by a lipid-
modified cysteine (6). The Opp system of L. lactis has the
capacity to transport peptides from 4 to at least 18 residues (4).
Kinetic analysis of binding of the peptides SLSQS, SLSQSKVLP,
SLSQSKVLPVPQ, RDMPIQA, and RDMPIQAF to OppA of
L. lactis showed a relationship between the peptide dissocia-
tion constants (Kd) and the length of the ligand (14), varying
from millimolar values for SLSQS to submicromolar values for
SLSQSKVLPVPQ.
The crystal structures of the oligopeptide binding protein
(OppA) from Salmonella enterica serovar Typhimurium in
complex with tripeptides (34), tetrapeptides (33), or dipeptides
as well as unliganded binding proteins (31) have been solved,
and the residues involved in interactions with the peptides have
been identified. The main chain of the peptide is in an ex-
tended conformation and forms parallel and antiparallel
b-sheet interactions with some residues of OppA. The N ter-
minus of the peptides forms a salt bridge with the side chain of
Asp-419. Arg-413 and His-371 each form a salt bridge with the
carboxylate groups of the tri- and tetrapeptide ligands, respec-
tively, and Lys-307 has been postulated to form a salt bridge
with the C terminus of pentapeptides. In the case of the dipep-
tide, the C-terminal interaction with OppA is indirect and
occurs via a water molecule that interacts with the side chain of
Arg-404 and Arg-413. The side chains of the peptides are
accommodated in spacious and hydrated pockets, where few
direct contacts are made with the protein. Water molecules act
as flexible adapters that match the hydrogen-bonding require-
ments of OppA and the ligand and/or shield charges on the
buried ligand (35). The peptides are buried within OppA,
according to the Venus flytrap mechanism (19).
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In line with the similar three-dimensional structures of the
OppA protein of serovar Typhimurium (OppASt) and the
dipeptide binding protein DppA of E. coli and the relatively
low degree of identity in primary sequence between these
proteins, it seems likely that OppASt and L. lactis (OppALl)
also have a similar structural fold (27); the amino acid identity
between these proteins is 21 to 22%. Comparison of OppASt
and OppALl shows that of the important residues that interact
with the peptides in OppASt, only Lys-307 is conserved in
OppALl (Fig. 1). On the basis of the structure of OppASt
protein, we made amino acid substitutions in OppALl that
should be near or at the peptide binding site. The effects of
these substitutions on the growth of L. lactis as well as in vivo
peptide transport and peptide binding to purified OppA are
reported in this paper.
MATERIALS AND METHODS
Strains, growth conditions, media, and chemicals. All strains and plasmids are
listed in Table 1. E. coli BZ234 was grown at 37°C with vigorous aeration in Luria
broth (29), supplemented with 500 mg of erythromycin per ml when carrying
plasmids pAMP21 or pAMP31. L. lactis strains were grown in M17 broth (Difco
Laboratories, East Molesey, United Kingdom) at 30°C as stand cultures or on
M17 broth solidified with 1.5% agar (36) supplemented with 0.5% (wt/vol)
glucose and 5 mg of erythromycin per ml, if required. For purification purposes,
the L. lactis strains were grown in fed batch in 10-liter fermentors with pH
control (ADI 1065 fermentor; Applikon Dependable Instruments, B. V., Schie-
dam, The Netherlands). The pH value was kept constant at 6.5 by the addition
of 1 M KOH. Complementation studies were performed on plates or liquid
cultures of chemically defined medium (CDM) (25) lacking leucine and contain-
ing a tetra- or pentapeptide (400 mM, final concentration) as the sole source of
leucine. All peptides used were from Bachem Feinchemikalien AG (Bubendorf,
Switzerland); Na125I (2,145 Ci/mmol) and [3,4(n)-3H]-bradykinin (71 Ci/mmol)
were obtained from Amersham (Buckinghamshire, United Kingdom); Ni-nitrilo-
triacetic acid resin was from Qiagen, Inc.; n-dodecyl-b-D-maltoside (DDM) was
from Sigma (St. Louis, Mo.). All other chemicals were of reagent grade and were
obtained from commercial sources.
General DNA techniques. Plasmid and chromosomal DNA were isolated by
the alkaline lysis method as previously described (29). PCR was performed with
VENT DNA polymerase (New England Biolabs). After 30 cycles of amplifica-
tion, the PCR products were purified using the QIAquick spin PCR purification
kit (Qiagen). DNA modification enzymes were obtained from Boehringer GmbH
(Mannheim, Germany). Digestions were carried out according to the manufac-
turer’s recommendations. Ligation of DNA fragments was performed as de-
scribed previously (29). L. lactis was transformed by electroporation as described
(9). DNA was sequenced by the dideoxy-chain termination method (30) using T7
DNA polymerase.
Construction of oppA deletion mutants. The oppA gene was deleted from the
chromosome of L. lactis MG1363 and IM15 via homologous recombination (16).
An integration plasmid, pAP2, which contains the 59 and 39 flanking sequences
of oppA was constructed for this purpose. Both flanking regions were amplified
by PCR using pVS8 (37) as template and the primers FBB plus RCP (59 region)
and FOP plus ROS (39 region). Primers are listed in Table 2. The PCR products
corresponding to the 59 (1,086 bp) and 39 (1,096 bp) flanking regions were
restricted with BamHI plus PstI and PstI plus SphI, respectively, and ligated into
the multiple cloning site of pORI280 (15). L. lactis MG1363 and IM15 were
transformed with pAP2, and transformants were selected on CDM plates, sup-
plemented with X-Gal (5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside) plus
erythromycin. Blue colonies arose from the integration of the plasmid at one of
the two loci. Subsequently, the recombinant strains were grown on CDM liquid
medium without erythromycin for about 100 generations to allow for another
recombination event. A number of white colonies were selected on CDM plates
supplemented with X-Gal and further analyzed by PCR and Western analysis.
oppA expression vector. The oppA gene was obtained by PCR using pVS8 as
template and the primers FA and RAB (oppA without the nucleotide sequence
coding for the signal sequence; oppADss) or FSA and RAB (oppA including the
nucleotide sequence for the signal sequence). In both cases, a unique NcoI site
was engineered at the translation initiation site. Both PCR products were di-
gested with NcoI plus BamHI, ligated into the vector pGKHis (10), which places
the gene fragments in frame with a sequence specifying a 6-His tag at the C
terminus of the protein. The StuI-NcoI (2,783 bp) fragment containing the cat
and galM genes and the lacS promoter region was replaced by a PCR product
that specifies the P32 promoter of L. lactis subsp. cremoris Wg2 (41). The P32
PCR product (191 bp) was obtained using pMG36e (38) as template and the
primers FP32S and RP32. The resulting plasmids were named pAMP21 (OppA
without signal sequence) and pAMP31 (OppA with signal sequence).
Immunogold labelling. Immunogold labelling of ultrathin sections of L. lactis
IM15, AMP2/pAMP21, and AMP2/pAMP31 with polyclonal antibodies raised
against OppA (20) (1:2,000 serum dilution) was performed as previously de-
scribed (32). Samples were analyzed with a Philips CM 10 transmission electron
microscope.
FIG. 1. Alignment of parts of the OppA proteins from L. lactis and S. enterica serovar Typhymurium. Sequences of the putative peptide binding region were aligned
using the CLUSTAL X program. Conserved residues are marked with an asterisk, while similar residues are marked with a single or double dot. N, C3, C4, and C5
correspond to interactions of OppASt with the N terminus of peptides and the C terminus of tri-, tetra-, and pentapeptides, respectively. Characters in boldface
represent the identified peptide binding residues in serovar Typhimurium and their putative counterparts in L. lactis. Substitutions made in OppALl are also indicated
by arrows.
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Sequence alignment. A multiple alignment of the OppA protein from serovar
Typhimurium, DppA protein from E. coli (22), and OppA from L. lactis was
generated using the CLUSTAL X program. A gap penalty of 30 and an extension
gap penalty of 0.05 were used. The alignment was then manually modified to
prevent gaps in the sequences that aligned with the known secondary structure
elements of OppASt and DppA.
Construction of mutants of OppA. Oligonucleotide-directed site-specific mu-
tagenesis was used to generate single mutations in OppA. The mutants were
constructed by a two-step PCR method. The synthetic mutagenic primers used
are listed in Table 2. The oligonucleotides XbaF plus XnYR (X, amino acid
residue present in OppA; n, position in the mature OppA; Y, mutated residue;
and R, reverse primer) and XnYF (F, forward primer) plus RAB were used as
primers in the first PCR step with plasmid pAMP31 as template. Subsequently,
both PCR products were purified together and used as template for the second
PCR step with the oligonucleotides XbaF plus RAB. The resulting 1,483-bp
fragments were digested with XbaI plus BamHI and exchanged for the equivalent
fragment of pAMP31. All 1,465-bp XbaI-BamHI fragments were checked by
nucleotide sequencing.
Western analyses. L. lactis cells were harvested at the end of the exponential
phase of growth, washed once with water, and resuspended in water to A660 of
approximately 10. The cells were sonicated for nine cycles of 5 s at an amplitude
of 4 mm with 15 s cooling, on ice, using an MSE Soniprep 150-probe sonicator
(Crawley, United Kingdom). Subsequently, sample buffer was added and the
lysates were boiled for 5 min. Cell debris was removed by centrifugation (12,000
TABLE 1. Bacterial strains and plasmids
Strain or plasmid Relevant characteristic(s) Source or reference
Strains
L. lactis
MG1363 Plasmid-free derivative of NCD0712; Lac2 Prot2 5
IM15 MG1363 DpepX DpepT DpepC DpepN 20
AMP15 MG1363 DoppA This work
AMP2 IM15 DoppA This work
E. coli
BZ234 C600 derivative; Ems
Plasmids
pVS8 Cmr; pSH71 replicon; opp operon of L. lactis 37
pORI280 Emr; lacZ1; deletion derivative of pWV01 lacking repA 16
pAP2 pORI280 containing the 59 and 39 flanking regions of oppA This work
pSKII(1) Carbr; high-copy-number expression vector Stratagene
pSKE8His pSKII(1)-derivative carrying lacS with NcoI site on the initiation codon and a C-terminal
His tag
10
pGK13 Emr Cmr; pWV01 replicon; E. coli-L. lactis shuttle vector 11
pGKGS8 pGK13 derivative carrying lacS as a 3,784-bp EcoRI-DraI fragment from pSKE8His
ligated into the EcoRI-EcoRV sites
10
pMG36e P32 promoter of L. lactis subsp. cremoris Wg2; Emr 38
pAMP21 pGK13 derivative with oppA as a 1,736-bp NcoI-BamHI fragment This work
pAMP31 pGK13 derivative with oppA as a 1,802-bp NcoI-BamHI fragment This work
pAMP31(K349Q) pAMP31 with Lys-349 of OppA-His6 replaced by Gln This work
pAMP31(N422H) pAMP31 with Asn-422 of OppA-His6 replaced by His This work
pAMP31(A423H) pAMP31 with Ala-423 of OppA-His6 replaced by His This work
pAMP31(D471R) pAMP31 with Asp-471 of OppA-His6 replaced by Arg This work
pAMP31(A477D) pAMP31 with Ala-477 of OppA-His6 replaced by Asp This work






















a Nucleotides in boldface type correspond to restriction site; nucleotide changes that give rise to an amino acid substitution are underlined.
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3 g; 3 min). Samples (20 mg/lane) were subjected to sodium dodecyl sulfate
(SDS)–10% polyacrylamide gel electrophoresis, and the proteins were trans-
ferred to polyvinylidene difluoride sheets (Millipore) by semidry electroblotting
(13). OppA was detected with polyclonal anti-OppA antibodies (1:20,000 serum
dilution) using the Western-Light chemiluminescence kit with CSPD as substrate
(Tropix, Inc.).
Iodination of the tetrapeptide KYGK. The tetrapeptide KYGK was iodinated
at the tyrosine residue with the iodinating reagent 1,3,4,6-tetrachloro-3a, 6a-
diphenylglycouril (Pierce Chemical Co., Rockford, Ill.) plus 200 mCi of Na125I
(2,145 mCi/mmol; Amersham) as previously described (4).
Transport assays. Cells grown to an optical density at 600 nm of 1.0 were
harvested by centrifugation, washed twice, and resuspended in buffer A (100 mM
potassium phosphate [pH 6.5], 5 mM magnesium sulphate). A total of 50 ml of
the cell suspension (’1.2 mg of protein/ml for KYGK uptake; ’0.17 mg of
protein/ml for bradykinin uptake) was added to 200 ml of buffer A supplemented
with glucose (25 mM final concentration). Cells were incubated for 3 min at 30°C
(in assays with KYGK as substrate) or 10°C (bradykinin as substrate), after which
the transport reaction was initiated by the addition of 5.85 mM 125I-KYGK or 0.7
mM bradykinin (3H-RPPGFSPFR diluted with RPPGFSPFR), unless specified
otherwise. At given time points, 50-ml samples were withdrawn and diluted with
2 ml of ice-cold 0.1 M LiCl. The samples were rapidly filtered through 0.45-mm-
pore-size cellulose-acetate filters (Schleicher & Schuell GmbH, Dassel, Ger-
many) and washed with 2 ml of ice-cold 0.1 M LiCl. The radioactivity of the filter
was determined by liquid scintillation. To estimate the binding, the same proce-
dure was followed except that the cells were incubated in buffer A without
glucose for 6 min, and the amount obtained for strain AMP2 was subtracted in
all cases. To determine the kinetic constants for bradykinin uptake, the amounts
of bradykinin were varied from 0 to 5 mM. The uptake rate for each concentra-
tion was calculated by linear regression from the intracellular peptide concen-
tration at different time points up to 90 s. The uptake rate as a function of the
substrate concentration was fitted to the Michaelis-Menten equation.
Purification of OppA-His6. Membrane-bound OppA-His6 was purified from
inside-out membrane vesicles of L. lactis. The membrane vesicles were isolated
as previously described (26) and solubilized at 5 mg of protein/ml in buffer B (50
mM potassium phosphate, 100 mM KCl, 10% glycerol [pH 7.6]) plus 0.2%
(wt/vol) DDM. The mixture was incubated on ice for 30 min, and the insoluble
material was removed by centrifugation (280,000 3 g; 15 min). The solubilized
membrane proteins were mixed with Ni-nitriloacetic acid resin previously equil-
ibrated with buffer B. The mixture was incubated for 1 h at 4°C under continuous
shaking and subsequently poured into a Bio-spin column (Bio-Rad). The column
was washed with 20 column volumes of buffer B, pH 6.5, plus 0.05% DDM
supplemented with 15 mM imidazole. The protein was eluted with buffer B plus
0.05% DDM containing 500 mM imidazole. A desalting step on a PD10 column
(Bio-Rad) was performed in order to remove the imidazole. All handlings were
performed at 4°C. The endogenous ligand copurified with OppA was removed by
controlled denaturation-renaturation with 2 M guanidinium-HCl as described
(14), except that 0.05% DDM was present in all solutions.
NCE. Samples (each, 1 mg of protein) were prepared by incubating OppA-His6
with an equimolar amount of trypsin for 1 h at 30°C. The reaction was stopped
by adding a 10-fold excess of trypsin inhibitor. When appropriate, peptide was
added at a final concentration of 1 mM, and the mixture was incubated for 5 min
at room temperature. Native cationic gel electrophoresis (NCE) was performed
according to the method of Reisfield et al. (28) with some modifications (13).
Intrinsic protein fluorescence. Peptide binding to OppA-His6 was observed as
changes in intrinsic protein fluorescence, as previously described (14), except
that 0.05% DDM was present in the buffer solution. All measurements were
done in an Aminco 4800 spectrofluorimeter. The effect of peptide addition on
fluorescence was measured at 15°C by exciting OppA (0.6 mM) at 280 nm with
a slit width of 2 nm and measuring the emission at 315 nm with a slit width of 8
nm. Data analyses were performed as previously described (14).
Miscellaneous. Protein content was determined according to Lowry et al. (17)
with bovine serum albumin as standard. The concentration and stability of
purified OppA proteins were evaluated by measuring the absorption spectrum
between 240 and 340 nm. The extinction coefficient of OppA was calculated as
previously described (24), obtaining a value of 1.605 (mg/ml)21 z cm21.
RESULTS
Analysis of oppA deletion mutants of L. lactis. To study the
properties of wild-type and mutant alleles of OppA in vivo, the
oppA gene was deleted from the chromosome of strains
MG1363 and IM15 by a crossover in each of the flanking
regions with the integration plasmid pAP2. This procedure
allows the complete deletion of oppA, leaving intact the other
genes of the opp operon. Some putative mutants were analyzed
by PCR, and the absence of the OppA protein was confirmed
by immunoblotting. One mutant of each parent strain was chosen
for further studies and named L. lactis AMP15(MG1363 DoppA)
and L. lactis AMP2(IM15 DoppA) (Fig. 2).
Lactic acid bacteria are multiple amino acid auxotrophs (3),
and their nitrogen requirements are met by taking up free
amino acids or peptides from the medium. Since it has been
proved that the Opp system is essential for the uptake of
peptides longer than three residues (12), the deletion of the
oppA gene should result in a strain unable to grow on peptides
as the source of one of these essential amino acids. Indeed, L.
lactis AMP15 was unable to grow on CDM liquid medium with
one of the tetra- or pentapeptides GLGL, LWMR, SLSQS,
and YGGFL as the sole source of leucine, whereas the strain
grew normally on CDM containing L-leucine. L. lactis IM15
is impaired in the degradation of peptides due to the deletion
of four peptidases, but it is still able to use leu-enkephalin
(YGGFL) as a source of leucine. As anticipated, L. lactis AMP2
was unable to grow on CDM plates containing 100 mM of
leu-enkephalin as a sole source of leucine, whereas the strain
grew normally on CDM plates containing L-leucine. To show
directly that L. lactis AMP2 is defective in oligopeptide uptake,
we monitored the uptake of 3H-bradykinin. Transport of bra-
dykinin was completely abolished in L. lactis AMP2, whereas
the uptake rate in the parent strain (IM15) was about 400
pmol z min21 z mg of protein21 (Fig. 3).
FIG. 2. Immunoblot of wild-type and mutant OppA proteins. Total cell ly-
sates were resolved by SDS–10% polyacrylamide gel electrophoresis, transferred
to a polyvinylidene difluoride membrane, and probed with antibodies raised
against OppA. Lysates of IM15, AMP2, AMP2/pAMP31, AMP2/pAMP31(K349Q),
AMP2/pAMP31(N422H), AMP2/pAMP31(A423H), AMP2/pAMP31(D471R),
AMP2/pAMP31(A477D), and IM15 are indicated; 20 mg of protein was present
in each lane.
FIG. 3. Bradykinin uptake by L. lactis IM15 (F), AMP2 (E), AMP2/pAMP21
(), and AMP2/pAMP31 (). The cells were energized for 3 min prior to the
addition of bradykinin (0.7 mM, final concentration) at time zero. The intercept
with the y axis reflects the amount of bradykinin binding to the cells.
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L. lactis AMP2 was tested as host for the expression of
OppA with the plasmid pAMP21 or pAMP31. Both plasmids
contain the oppA gene under the control of the P32 promoter,
and the genes are fused to a sequence that specifies a 6-His tag.
Unlike in pAMP31, the oppA gene in pAMP21 lacks the signal
sequence. The protein specified by oppADss is referred to as
OppA*. As anticipated, pAMP21(oppADss) was unable to re-
store the ability of L. lactis AMP2 to utilize leu-enkephalin as
a source of leucine (data not shown), and the transport of brady-
kinin was negligible (Fig. 3). L. lactis AMP2/pAMP31(oppA) was
able to use leu-enkephalin as a source of leucine and trans-
ported bradykinin with an uptake rate of about 550 pmol z
min21 z mg of protein21 (Fig. 3).
Overall, the results demonstrate that the oppA gene has
been deleted from the chromosome of L. lactis MG1363 and
IM15 and that OppA is the only binding protein that allows the
organism to transport the tested oligopeptides. Complementa-
tion occurs with the oppA gene in trans.
Overexpression and localization of OppA. The amount of
OppA present in AMP2/pAMP31 was approximately eight
times higher than the level present in the parent strain (data
not shown). Electron microscopy studies showed that all OppA
produced by AMP2/pAMP31 was localized at the surface of
the cell (Fig. 4). As was anticipated, OppA* was found in the
cytoplasm of strain AMP2/pAMP21, due to the lack of a signal
sequence. The observation that the rate of bradykinin uptake
by AMP2/pAMP31 is at best 40% higher than that of IM15,
whereas the expression level of OppA increased eightfold,
indicates that transport of this peptide is not to a large extent
rate determined by OppA activity.
Expression of site-specific mutant OppA proteins. The ter-
tiary structure of OppA of serovar Typhimurium has been
elucidated, and the specific residues that may interact with the
termini of different peptides have been identified (33). OppA of
serovar Typhimurium (OppASt) and OppA of L. lactis (OppALl)
are homologous, but the identity between the two proteins is
only 21 to 22%. A comparison of the primary sequence of both
proteins (Fig. 1) shows that only Lys-307 in OppASt, which
interacts with the carboxy terminus of the pentapeptides, is
conserved in OppALl (Lys-349). The identification of the other
residues that, on the basis of the OppASt structure, could
interact with the termini of the peptides is more ambiguous.
The residues equivalent to Asp-419 (N terminus of peptides),
Arg-413 (C terminus of tripeptides), and His-371 (C terminus
of tetrapeptides) in OppALl could be Ala-477, Asp-471, and
Asn-422 or Ala-423. To establish the possible role of these
residues in peptide binding and transport, substitutions were
made on the basis of the structure of OppASt, yielding the
following OppALl mutants: K349Q, A477D, D471R, N422H,
and A423H.
The plasmids bearing the mutant genes were transformed to
strain AMP2. Expression of these mutant OppA proteins was
tested by Western analysis in whole cells and in membrane
vesicles. In all cases, OppA was present in the membrane
fraction and the mutant proteins were produced in amounts
comparable to that of the wild-type protein expressed from
plasmid pAMP31 (Fig. 2). Mutant D471R had an altered elec-
trophoretic mobility as compared to wild-type OppA, which
disappeared in the presence of 6 M urea (data not shown).
In vivo function of mutant OppA proteins. To determine if
these mutant proteins were able to complement the deletion
mutants, L. lactis AMP15 and AMP2 were transformed with one
of the following plasmids; pAM31(K349Q), pAMP31(N422H),
pAMP31(A423H), pAMP31(D471R), or pAMP31(A477D).
Transformants were tested for their ability to use oligopeptides
(GLGL, LWMR, SLSQS, and YGGFL) as the sole source of
leucine. All mutant OppA proteins sustained growth on these
tetra- or pentapeptides as the sole source of leucine and had
growth rates similar to that of the wild-type protein (data not
shown).
Binding of bradykinin to cells expressing wild-type or mu-
tant OppA proteins. The data presented in Fig. 3 show that the
increased amount of OppA present in strain AMP2/pAMP31
resulted in a slightly increased uptake rate but a highly in-
creased binding (340 pmol z min21 z mg of protein21 when the
uptake curve is extrapolated to time zero). To evaluate the
binding of bradykinin quantitatively, the cells were incubated
in buffer A without glucose for 6 min, and the amount of bound
bradykinin was determined. Under these conditions, the cells
FIG. 4. Immunogold labeling of ultrathin sections of L. lactis cells expressing
wild-type OppA (A and C) or OppA* (lacking signal sequence) (B). The proteins
were detected with polyclonal antibodies raised against OppA. Panel A, IM15
cells; panel B, AMP2/pAMP21 cells; and panel C, AMP2/pAMP31 cells.
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did not accumulate the substrate and since the binding of
bradykinin to OppA appeared to be tight, it could be quanti-
fied by the filtration assay. L. lactis AMP2/pAMP31 bound
approximately seven times more bradykinin than IM15, whereas
binding to the OppA mutants K349Q, A423H, D471R, and
A477D was similar to that of IM15, at a bradykinin concen-
tration of 0.7 mM (Table 3). The N422H mutant displayed
intermediate binding. Since the expression levels of these mu-
tant proteins were similar to that of wild-type OppA and func-
tional complementation was observed in growth experiments,
the data are consistent with a reduced affinity for bradykinin
(see below) but, at this point, it cannot be ruled out that part
of the mutant proteins is inactive.
Transport of peptides by cells expressing wild-type or mu-
tant OppA proteins. KYGK and bradykinin are low- and high-
affinity substrates, respectively, of the Opp system of L. lactis
(4, 14). Moreover, KYGK was used as substrate because it is
not degraded by strains IM15 and AMP2 due to their multiple
peptidase deficiencies. The rates of uptake of 125I-KYGK and
3H-bradykinin are shown in Table 3. Each of the mutant OppA
proteins restored the uptake of KYGK and bradykinin in the
AMP2 background, albeit to different levels. With the excep-
tion of OppA(D471R), the rates of KYGK uptake were com-
parable to that of the system with the wild-type OppA protein
(Table 3). The rates of bradykinin uptake by strains expressing
OppA proteins K349Q, N422H, and A477D were significantly
lower than that of the wild type. The rate of uptake by strain
expressing OppA(D471R) was much higher for both peptides
(fivefold for KYGK and threefold for bradykinin).
Strain AMP2/pAMP31(D471R) was studied further because
of its exciting properties, that is an apparent decreased binding
affinity for bradykinin and an increased transport activity. To
establish whether these properties are also manifested in the
kinetic parameters of transport (Km and Vmax), we determined
the uptake rate as a function of the bradykinin concentration and
compared the obtained Km and Vmax values to the data obtained
for strain AMP2/pAMP31 (Table 4). Strain AMP2/
pAMP31(A477D) was also characterized as an example of a
system that displayed reduced binding and transport activity.
The differences in transport rate between the wild type and
mutants were mainly at the level of Vmax, but a small but
significant change in Km was also observed for OppA(A477D).
Thus, the apparent decrease in binding affinity for bradykinin
by OppA(D471R) is accompanied by a higher Vmax for uptake
(see Discussion for interpretation).
Peptide binding studied by NCE. It has been shown that
OppA* (expressed from plasmid pAMP21) exhibits a shift in
mobility in the presence of oligopeptides (14). The method
provides direct proof for the ability of the protein to bind
peptide, and it yields semiquantitative information about the
dissociation constants. It was used to study peptide binding to
OppA(WT), OppA(D471R), and OppA(A477D). Each of the
proteins was purified, the endogenous ligand was removed by
guanidinium-HCl treatment, and the amino-terminal lipid an-
chor-signal sequence was removed by trypsin treatment. The
FIG. 5. Concentration dependence of the fluorescence increase at 315 nm
induced by peptides binding to OppA(WT) (F), OppA(D471R) (E), and
OppA(A477D) () in the presence of bradykinin (RPPGFSPFR) (A) and
SLSQSKVLP (B). The concentration of all OppA proteins in this experiment
was 0.6 mM. The solid line through the data points represents the best fit. The Kd
values obtained for OppA(WT) were 0.29 6 0.02 for bradykinin and 2.07 6 0.07
for SLSQSKVLP. The Kd values for OppA(D471R) were 2.83 6 0.09 for bra-
dykinin and 2.26 6 0.05 for SLSQSKVLP. The Kd values for OppA(A477D)
were 20.86 6 0.56 for bradykinin and 6.22 6 0.13 for SLSQSKVLP.
TABLE 3. Binding of bradykinin (RPPGFSPFR) and uptake of









AMP2 0a ,0.2 15 6 10
IM15 39 6 5 ND 400 6 40
AMP2/pAMP31(WT) 286 6 20 5 6 1 550 6 40
AMP2/pAMP31(K349Q) 56 6 6 4 6 1 33 6 10
AMP2/pAMP31(N422H) 106 6 9 ND 39 6 11
AMP2/pAMP31(A423H) 32 6 4 3 6 1 ND
AMP2/pAMP31(D471R) 51 6 4 28 6 3 1,600 6 50
AMP2/pAMP31(A477D) 30 6 3 6 6 2 53 6 10
a The amount of bradykinin bound to AMP2 (40 6 4) was subtracted in all
cases. Bradykinin (3H-RPPGFSPFR), (0.7 mM) final concentration.
b Uptake rates are in picomoles of peptide per milligram of protein per
minute. Rates are shown as means 6 standard errors. ND, not determined.
TABLE 4. Kinetic parameters for bradykinin uptake
in L. lactis cells
Strain Vmaxa Km (mM)
AMP2/pAMP31(WT) 1,095 6 106 0.27 6 0.03
AMP2/pAMP31(D471R) 2,407 6 228 0.24 6 0.04
AMP2/pAMP31(A477D) 111 6 48 0.54 6 0.06
a Vmax values are in picomoles per milligram of protein per minute. Rates are
shown as means 6 standard errors.
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latter step was performed because the lipid anchor prevented
entry of the protein into the polyacrylamide gel. NCE of tryp-
sin-treated OppA(WT) and OppA(A477D) yielded two spe-
cies that correspond to the open unliganded and the closed
liganded forms of OppA (14). Upon addition of bradykinin or
SLSQSKVLPVPQ, the fast-migrating form became predomi-
nant. In the case of OppA(D471R), only one form was ob-
served before and after incubation with peptides (data not
shown). Due to the altered electrophoretic mobility of
OppA(D471R) even in the presence of SDS, it was not possi-
ble to conclude if this unique form corresponds to the open or
closed conformation.
Peptide binding studied by intrinsic protein fluorescence.
To study the binding of peptides in a more quantitative man-
ner, purified and guanidinium-HCl-treated OppA(WT),
OppA(D471R), and OppA(A477D) were used in intrinsic pro-
tein fluorescence assays. The emission spectrum of OppA
showed a maximum at 332 nm. Upon binding of peptides, a
blue shift of approximately 2 nm was observed. Binding of
bradykinin or SLSQSKVLP resulted in an increase in fluores-
cence below 340 nm and in a decrease above 340 nm (data not
shown). The increase in fluorescence at 315 nm was concentration
dependent and could be used to determine the kinetic parameters
for peptide binding. Binding of bradykinin and SLSQSKVLP to
OppA(WT), OppA(D471R), and OppA(A477D) yielded a de-
pendence on the peptide concentration that could be equated
with DF 5 (Fmax*[S])/(Kd1[S]), where DF is the observed fluo-
rescence change, Fmax is the maximal change in fluorescence, Kd
is the dissociation constant, and [S] is the peptide concentration
(Fig. 5). The dissociation constants determined for bradykinin
were 0.29 mM for OppA(WT), 2.83 mM for OppA(D471R), and
20.9 mM for OppA(A477D). The Kd values of the three proteins
were of the same order of magnitude when the nonapeptide
SLSQSKVLP was used as test substrate. These results indicate
that the mutations affect the affinity of OppA for bradykinin but
not the affinity for peptides in general.
DISCUSSION
In this paper, we show that deletion of the oppA gene from
the chromosome rendered L. lactis MG1363 and IM15 inactive
in the uptake of oligopeptides. These strains could be comple-
mented with the oppA gene in trans. The presence of a His tag
at the C terminus did not affect the functionality of OppA; all
of the overexpressed protein was directed to the cell surface as
shown by the electron microscopy studies. The increase in the
expression of OppA resulted in a highly increased peptide
binding capacity, whereas the uptake rate was only marginally
affected. These initial studies have set the stage for the in vivo
and in vitro analyses of mutations in the peptide binding pro-
tein of the Opp system of L. lactis.
Several site-directed mutants of OppA were constructed on
the basis of a comparison between the primary sequence of
OppA from serovar. Typhimurium and L. lactis, taking advan-
tage of the three-dimensional structure of OppASt. The expres-
sion of all of these mutant OppA proteins restored the trans-
port of peptides as well as the growth of DoppA mutants of
MG1363 and IM15 on peptides as a source of essential amino
acids. Mutant D471R displayed a five- and threefold-higher
uptake rate for KYGK and bradykinin (RPPGFSPFR), respec-
tively. The rate of transport of KYGK was not significantly
affected in the other mutants, whereas that of bradykinin was
approximately 10-fold lower. The apparent increase in uptake
rate in OppA(D471R) and the decrease in OppA(A477D)
correspond to a change in Vmax rather than to large alterations
in the affinity constants for uptake. Studies of peptide binding to
wild-type and mutant OppA proteins showed that the Kd values
for bradykinin binding to OppA(D471R) and OppA(A477R) in-
creased by 1 and 2 orders of magnitude, respectively, as compared
to OppA(WT). The same proteins exhibited wild-type binding
kinetics for the other nonapeptide tested (SLSQSKVLP). The
consequences of these differences in Kd and Km values and their
dependence on the actual peptide used are discussed below.
Since the Kd for bradykinin binding to OppA(D471R) and
OppA(A477R) was greatly increased, it was not possible to
determine the binding stoichiometry for these mutants. To
determine the actual number of binding sites, one needs a
high-affinity ligand such that Kd ,, [OppA] under the exper-
imental conditions (see our previous analysis in reference 14).
In our opinion, the diminished amount of bradykinin binding is
consistent with the increase in Kd and does not involve a
decrease in the binding stoichiometry as a result of a fraction
of inactive protein. This notion is supported by the observation
that the kinetics of SLSQSKVLP binding to OppA(D471R) is
very similar to that of the wild-type protein.
FIG. 6. In this scheme, E and EL represent the unliganded and liganded binding protein, respectively; Lo and Li are the external and internalized ligand,
respectively; and M refers to the membrane-bound complex.
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Comparison of the specificities of OppALl and OppASt in
relation to the structure. All the mutations introduced into
OppALl seem to affect the specificity of the protein for pep-
tides. The positions were selected for mutagenesis studies on
the basis of their proposed interactions with the tri-, tetra-, or
pentapeptides in OppASt. The selected residues in OppALl
clearly have a more global effect on the interactions with the
peptides, as pronounced differences in transport and binding
activities were observed when the nonameric peptide bradyki-
nin was used as test substrate. Since the transport of peptides
by Opp is rate determined by the kinetics of bradykinin binding
to only a small extent, changes in this parameter may not be
observed in the overall transport reaction. The same may apply
for other peptides, and it would require a full analysis of both
peptide binding and transport. Unfortunately, the availability
of radiolabelled oligopeptides for transport studies is limited,
whereas the dissociation constants of small peptides (five or
fewer residues) are too high (in the millimolar range) to be
analyzed by NCE or intrinsic fluorescence. As a consequence,
we cannot rule out the possibility that some of the mutants
have an altered Kd for tripeptides (D471R) or tetrapeptides
(N422H or A423H) specifically.
In our opinion, however, the fact that these residues are not
conserved may reflect the differences in function of both OppA
proteins; that is, OppALl serves to accumulate rather long
peptides (.5 residues) (4), whereas the optimal activity of
OppASt is for tri- and tetrapeptides (7). Part of the binding
affinity of OppASt for tri- and tetrapeptides will be obtained
from the interactions of the carboxyl-terminal ends of these
peptides with the corresponding residues in the protein. The
dissociation constants of OppALl for tri- and tetrapeptides are
much higher than those of OppASt, most likely because the
interactions with the termini of the peptides are absent. In this
regard, it is worth emphasizing that, despite the high dissoci-
ation constants of OppALl for tri- and tetrapeptides, all the
peptides tested thus far are taken up by Opp of L. lactis (4); the
capacity of OppLl to transport tripeptides is more ambiguous.
A moderate decrease in binding affinity results in an higher
uptake rate. The Kd obtained for bradykinin for OppA(D471R) is
about 10-fold higher than that of OppA(WT). This difference
is in agreement with the observed lower-binding activity in cells
expressing OppA(D471R). Due to its very fast association, it
was not possible to determine the association (k1) and disso-
ciation (k21) rates for bradykinin by stopped-flow fluorescence
measurements. Nevertheless, we speculate that the increased
Kd of OppA(D471R) for bradykinin is caused by an increased
dissociation rate constant (k21). This suggestion follows from
the observation that the large variation in Kd of OppA* for a
range of peptides relates to differences in k21 (14). Site-di-
rected mutagenesis studies of the arabinose-binding protein of
E. coli (40, 41) also showed that variations in Kd relate to an
altered k21 rather than to a change in the association constant
(k1). This implies that bradykinin gains access to the active
sites of OppA(WT) and OppA(D471R) equally well but that
the dissociation rates from these binding proteins are different.
The consequences of this suggestion on the overall transport
by Opp can be analyzed from a previously published scheme
(14). According to this model (Fig. 6) transport takes place in
four steps: I, binding of the ligand to the binding protein; II,
docking of the liganded binding protein to the membrane
complex; III, donation of the ligand to the membrane complex;
and IV, translocation of the substrate across the membrane. It
has been proposed that the donation of the ligand from the
binding protein to the membrane-bound complex determines
the rate of the whole transport process (14, 21), which corre-
sponds to step III of the scheme. In this case, the rate of
transport can be described by the following equation:
v 5
k2@M0# @L#
KdLpSKdELKdE D 1 @L#
in which K92 is the rate constant of this donation step, [Mo] is
the total concentration of membrane-bound complex, [L] is the
concentration of the ligand, Kdl corresponds to the equilibrium
constant for binding of the ligand to the binding protein (k21/
k1), KdEL is the equilibrium constant for binding of the unligan-
ded binding protein to the membrane complex. If we assume
that k21 and k92 are related, that is, that the rate of dissociation
of the peptide from OppA is the same for free (EL) and
membrane-docked (EL:M) binding protein, then the rate of
transport will increase in proportion to k92. In other words, the
increase in Vmax for bradykinin uptake in OppA(D471R) re-
flects an enhanced donation of the peptide from the binding
protein to the membrane complex.
A large decrease in binding affinity results in a lower uptake
rate. In cells expressing OppA(A477D), the lower Vmax value
for bradykinin uptake parallels a dramatic decrease in the
binding affinity of the OppA(A477D) protein for bradykinin. If
we assume that the increased Kd is a consequence of a higher
value for k21, and thus k92, then following the same line of
reasoning as in OppA(D471R), one would also expect an in-
creased rate of uptake for OppA(A477D). However, if the Kd
becomes too low, the equilibrium between liganded and unli-
ganded OppA will be towards unliganded binding protein and
step I in the scheme may become rate determining. In this
regard, it is worth noting that unliganded and liganded binding
proteins are believed to have a similar affinity for the mem-
brane complex in the case of the histidine system (2).
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